In patients with heart failure, SGLT2 inhibitors after TAVI are associated with major risk reductions in a clinical trial ...
Previous skepticism turns to optimism as the first clinical trials for transplantation with genetically edited pig kidneys ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback